An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
InnoPharmax Inc.
ClinicalTrials.gov Identifier:
NCT01678690
First received: August 29, 2012
Last updated: May 19, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2014
  Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)